Quiz #4. Test your knowledge on CAR T-cell Products

Axicabtagene ciloleucel is currently indicated for patients with which of the following hematological malignancies?
Relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Relapsed or refractory mantel lymphoma
Relapsed or refractory multiple myeloma
Relapsed or refractory follicular lymphoma
In which year were CAR T-cell therapies were first approved?
2017
2018
2019
2020
Which CAR T-cell therapy was recently approved for treating adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy?
Brexucabtagene autoleucel
Idecabtagene vicleucel
Lisocabtagene maraleucel
Brexucabtagene autoleucel
CAR T-cell therapies are only available in the US via a risk evaluation and mitigation strategy (REMS).
True
False
0
{"name":"Quiz #4. Test your knowledge on CAR T-cell Products", "url":"https://www.quiz-maker.com/QBG8JJL9A","txt":"Axicabtagene ciloleucel is currently indicated for patients with which of the following hematological malignancies?, In which year were CAR T-cell therapies were first approved?, Which CAR T-cell therapy was recently approved for treating adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys